Toleranzia AB
Pharmaceutical ManufacturingView the employees at
Toleranzia AB-
Kristian S. Member of the Board, Toleranzia AB
-
Södertälje, Stockholm County, Sweden
-
Top 5%
Bjorn Lowenadler CBO på Toleranzia AB-
Rising Star
Andranik Durgaryan Senior Cell Biologist at Toleranzia AB-
Top 5%
sashidhar bandaru Senior scientist, team lead in immunology-
Greater Gothenburg Metropolitan Area
-
Top 5%
Maria Fernandez Programme Director at Toleranzia AB-
Greater Gothenburg Metropolitan Area
-
Top 5%
Overview
Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. The company has a lead project in myasthenia gravis as well as a second project in ANCA vasculitis. Toleranzia is listed on the Nasdaq First North Growth Market and backed by strongly committed renowned specialist investors.
-